Prevalence of Bacterial and Mycobacterial Spondylodiscitis
Pyogenic (bacterial) spondylodiscitis accounts for approximately 54-78% of all spondylodiscitis cases, while tuberculous (mycobacterial) spondylodiscitis represents 10-16% of cases.
Epidemiologic Distribution
The relative prevalence varies significantly across studies and geographic regions:
Pyogenic Spondylodiscitis
- Most common form, representing 44.6-78% of all cases 1, 2, 3
- The most recent large study from 2026 found pyogenic cases comprised 78% of 114 patients 1
- A 2025 study reported 54% pyogenic cases 2
- Staphylococcus aureus is the causative organism in approximately 64% of pyogenic cases, though this proportion has been declining (from 34.5% in 2005 to 17.2% in 2023) 2, 4
Tuberculous Spondylodiscitis
- Accounts for 10-16% of cases in most contemporary series 1, 2, 3
- A 2025 study found 10% tuberculous cases 2
- A 2026 study reported 16% tuberculous cases 1
- Another large series found 15.2% tuberculous cases 3
Brucellar Spondylodiscitis
- Represents 6-40% of cases, with marked geographic variation 1, 5, 3
- In endemic regions (e.g., Greece), Brucella can account for up to one-third of spinal infections 6
- In non-endemic areas like the United States, brucellar spondylodiscitis is rare
Rising Incidence Trends
The overall incidence of spondylodiscitis is increasing substantially, particularly in aging populations 4, 7:
- In Germany, the age-adjusted incidence doubled from 5.41 to 10.02 cases per 100,000 persons between 2005-2023 4
- Mean patient age increased from 65.8 to 72.2 years over this period 4
- The proportion of patients ≥70 years rose from 42.6% to 62.3% 4
Important Clinical Context
Cases of Unknown Etiology
A substantial proportion (35%) of spondylodiscitis cases remain of unknown etiology despite diagnostic efforts 2. This reflects the challenge of microbiologic confirmation, with blood cultures positive in only 25-47% of all cases 2.
Geographic Considerations
The prevalence of specific etiologies depends heavily on:
- Endemic status for tuberculosis and brucellosis
- Population demographics (aging populations show higher pyogenic rates)
- Healthcare infrastructure and diagnostic capabilities
Mortality and Morbidity
In-hospital mortality has doubled from 3.25% to 6.79% over recent decades, likely reflecting the older, more comorbid patient population now affected 4.